[1]TAYYEM O, BILAL M, SAMUEL R, et al.Evaluation and management of variceal bleeding[J].Dis Mon, 2018, 64 (7) :312-320.
|
[2]LO GH, LIANG HL, CHEN WC, et al.A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding[J].Endoscopy, 2007, 39 (8) :679-685.
|
[3]PROCACCINI NJ, AI-OSAIMI AM, NORTHUP P, et al.Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding:A single-center U.S.analysis[J].Gastrointest Endosc, 2009, 70 (5) :881-887.
|
[4]ZENG XQ, MA LL, TSENG YJ, et al.Endoscopic cyanoacrylate injection with or without lauromacrogol for gastric varices:A randomized pilot study[J].J Gastroenterol Hepatol, 2017, 32 (3) :631-638.
|
[5]SOUSA M, FERNANDES S, PROENCA L, et al.The Baveno VIcriteria for predicting esophageal varices:Validation in real life practice[J].Rev Esp Enferm Dig, 2017, 109 (10) :704-707.
|
[6]SEO YS.Prevention and management of gastroesophageal varices[J].Clin Mol Hepatol, 2018, 24 (1) :20-42.
|
[7]FONIO P, DISCALZI A, CALANDRI M, et al.Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification[J].Radiol Med, 2017, 122 (9) :713-721.
|
[8]NEVENS F.Novel approaches to reducing the risk of variceal hemorrhage[J].Dig Dis, 2017, 35 (4) :397-401.
|
[9]KOCHHAR GS, NAVANEETHAN U, HARTMAN J, et al.Comparative study of endoscopy vs.transjugular intrahepatic portosystemic shunt in the management of gastric variceal bleeding[J].Gastroenterol Rep (Oxf) , 2015, 3 (1) :75-82.
|
[10]XUE H, ZHANG M, PANG JX, et al.Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding[J].World J Gastroenterol, 2012, 18 (48) :7341-7347.
|
[11]NOH DY, PARK SY, JOO SY, et al.Therapeutic effect of the endoscopic N-butyl-2-cyanoacrylate injection for acute esophagogastric variceal bleeding:Comparison with transjugular intrahepatic portosystemic shunt[J].Korean J Gastroenterol, 2004, 43 (3) :186-195.
|
[12]MAHADEVA S, BELLAMY MC, KESSEL D, et al.Cost-effectiveness of N-Butyl-2-Cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding[J].Am JGastroenterol, 2003, 98 (12) :2688-2693.
|
[13]WEILERT F, BINMOELLER KF.Endoscopic management of gastric varices[J].Tech Gastrointest Endosc, 2017, 19:90-95.
|
[14]KOZIEL S, KOBRYN K, PALUSZKIEWICZ R, et al.Endoscopic treatment of gastric varices bleeding with the use of n-butyl-2cyanoacrylate[J].Prz Gastroenterol, 2015, 10 (4) :239-243.
|
[15]CHANDRA S, HOLM A, EI ABIAD RG, et al.Endoscopic cyanoacrylate glue injection in management of gastric variceal bleeding:US tertiary care center experience[J].J Clin Exp Hepatol, 2018, 8 (2) :181-187.
|
[16]RIBEIRO JP, MATUGUMA SE, CHENG S, et al.Results of treatment of esophageal variceal hemorrhage with endoscopic injection of n-butyl-2-cyanoacrylate in patients with ChildPugh class C cirrhosis[J].Endosc Int Open, 2015, 3 (6) :e584-e589.
|
[17]de FRANCHIS R, Baveno V Faculty.Revising consensus in portal hypertension:Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension[J].J Hepatol, 2010, 53 (4) :762-768.
|
[18]CHEN M, ZHANG F, ZHANG M, et al.Clinical effect of transjugular intrahepatic portosystemic shunt combined with tissue adhesive embolization in treatment of gastroesophageal variceal rebleeding in cirrhotic patients[J].J Clin Hepatol, 2018, 34 (6) :1209-1214. (in Chinese) 陈敏, 张峰, 张明, 等.经颈静脉肝内门体分流术联合组织胶栓塞术治疗肝硬化食管胃静脉曲张再出血的效果分析[J].临床肝胆病杂志, 2018, 34 (6) :1209-1214.
|
[19]SIRAMOLPIWAT S.Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications[J].World J Gastroenterol, 2014, 20 (45) :16996-17010.
|
[20]ZHENG M, CHEN Y, BAI J, et al.Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondaryprophylaxis of variceal rebleeding in cirrhotic patients:Meta-analysis update[J].J Clin Gastroenterol, 2008, 42 (5) :507-516.
|
[21] GARCA-PAGN JC, CACA K, BUREAU C, et al.Early use of TIPS in patients with cirrhosis and variceal bleeding[J].NEngl J Med, 2010, 362 (25) :2370-2379.
|
[22]GU XS, BAI XM, CHENG L, et al.Analysis of mid-and longterm efficacy of transjugular intrahepatic portosystemic shunt for treatment of gastroesophageal varices bleeding[J].J Intern Med Concepts Pract, 2015, 10 (4) :266-271. (in Chinese) 顾星石, 白旭明, 程龙, 等.经颈静脉肝内门体静脉分流术治疗肝硬化上消化道出血的中远期疗效观察[J].内科理论与实践, 2015, 10 (4) :266-271.
|
[23]KKSAL AS, KAYACETIN E, TORUN S, et al.Splenic infarction after N-butyl-2-cyanoacrylate injection for gastric varices:Why does it happen?[J].Surg Laparosc Endosc Percutan Tech, 2013, 23 (5) :e191-e193.
|
[24]GABA RC.Transjugular intrahepatic portosystemic shunt creation with embolization or obliteration for variceal bleeding[J].Tech Vasc Interv Radiol, 2016, 19 (1) :21-35.
|
[25]CASADABAN LC, PARVINIAN A, MINOCHA J, et al.Clearing the confusion over hepatic encephalopathy after TIPS creation:Incidence, prognostic factors, and clinical outcomes[J].Dig Dis Sci, 2015, 60 (4) :1059-1066.
|
[26]RUDLER M, CLUZEL P, CORVEC TL, et al.Early-TIPSSplacement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival[J].Aliment Pharmacol Ther, 2014, 40 (9) :1074-1080.
|